Clinical trial
PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC
NCT00313482
Study timeline
Study start (unknown)2006-04-01Date precision: month
Registry last updated2012-05-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hormone Refractory Prostate Cancerunresolved
Interventions
SargramostimDRUG · verified · RxNorm: sargramostim
DocetaxelDRUG · verified · RxNorm: docetaxel
PrednisoneDRUG · verified · RxNorm: prednisone
Sponsors & collaborators
Veeda Oncologylead sponsor
Bayercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00313482 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.